Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review.

Lisa DubrofskyAnand SrivastavaDavid Z I Cherney

Published in: Canadian journal of kidney health and disease (2020)

Further work is needed in specific patient subgroups, including patients with chronic kidney disease stages IV and V, patients with kidney disease but lower levels of albuminuria, and in patients without diabetes.

Keyphrases

end stage renal disease
type diabetes
ejection fraction
newly diagnosed
cardiovascular disease
healthcare
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
skeletal muscle